Consistently, Notch1 inhibition sensitizes HNSCC cell lines to cisplatin [406] and enhances the efficacy of cisplatin by attenuating the population of chemotherapy-enriched CSC [407]. This evidence concerns the gene NOTCH1 and head and neck squamous cell carcinoma.